Cassava Sciences is developing an Alzheimer drug, which not just slow the disease, but reverses it! In February they announced some incredible data for their 6-month open label study. That was the reason for the massive price increase. After that, the share price started declining due to some uncertainty. But a few weeks ago they announced to present the 9-month data set on a huge scientific conference in July.
For me that's a very very positive signal! Just imagine - would you present a failure on such a big stage? Certainly NO! Personally I used this opportunity to buy more shares.
The anticipation of the data release has already started but I am still adding below 60$. The CEO already spreaded some excitement about the data. He didn't want to "spill the beans yet", since Cassava is not allowed to publish the new study data before the conference.
I am actually super bullish on this and can't wait to see the new data.
My price target per share is > 400$
Disclaimer: This is no financial advice! Do your own due diligence before investing! I am just sharing my thoughts on this.
I don't know if you've looked at your April graphing, and compared it to what actually has happened, but you were pretty much dead on. That's impressive! I agree that there's huge potential with Cassava. I've been attempting to figure out my price target for them. How did you come up with your >$400 assessment? Is that just gut, or have you performed an actual analysis on that?
Thinus5422
⋅
Thank you for chart. Agree. Do not sell this share. It is going to reward you abundantly over longer term.